Cancer Vaccines in Clinical Trials: Development and Regulatory Considerations
Cancer Vaccines in Clinical Trials: Development and Regulatory Considerations Designing and Executing Clinical Trials for Cancer Vaccines Introduction to Cancer Vaccines Cancer vaccines aim to stimulate the immune system to recognize and eliminate tumor cells by targeting tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs). They can be prophylactic, like HPV vaccines preventing cervical cancer, or…
Read More “Cancer Vaccines in Clinical Trials: Development and Regulatory Considerations” »